ExoCoBio

ExoCoBio® is a pioneering company in the field of regenerative aesthetics, focusing on exosome-based treatments derived from stem cells. Founded in South Korea, ExoCoBio® has rapidly become a leader in exosome technology, investing over USD 60 million in research and development. The company's flagship product line, ASCE+™, utilizes their proprietary ExoSCRT™ manufacturing process to create highly purified exosomes, which are clinically proven to promote skin rejuvenation, reduce inflammation, and improve overall skin health. ExoCoBio®'s products are registered as cosmetic products with regulatory bodies in Korea, the US, and Europe, and are widely used in minimally invasive procedures such as micro-needling and laser treatments. With over 40 patents and numerous clinical studies, ExoCoBio® continues to innovate and set new standards in the aesthetic industry​